Eidos Therapeutics Inc News
Eidos Reportedly Received $4.6 Billion Takeover Bid From Glaxo
The report came from Bloomberg, citing knowledgeable sources. Eidos already agreed to a takeover offer from BridgeBio Pharma.
Eidos Shares Jump on Plan to Be Bought by BridgeBio
BridgeBio is buying the 36.3% of Eidos it doesn't own for cash and stock valued at $73.26 a share.
Building Economic Strength: Cramer's 'Mad Money' Recap
Jim Cramer says if you want to see the U.S. economy's strength, look to Home Depot, where the consumer's confidence and influence remains healthy.
Canopy Growth, Okta, B&G Foods: 'Mad Money' Lightning Round
Jim Cramer takes a closer look at Canopy Growth, Okta, B&G Foods, Eidos Therapeutics, Select Medical Holdings and more.
Trevor Noah Has Many Potential Replacements at 'The Daily Show'
But Comedy Central could also do something really unexpected with its former flagship program.
Musk Reveals New Cybertruck Features That Will Amaze EV Buyers
Tesla is expected to start production of its highly anticipated futuristic truck in 2023.
Disney Gives Beloved Character a Starring Movie Role
A development team led by Seth Rogen is working on a production that centers on a less well-known character with a nonetheless devoted following.
Fed Inflation Gauge Speeds Higher In August, Adding To Rate Hike Bets
The Fed's preferred inflation gauge topped Street forecasts Friday, snuffing out hopes of a near-term change in the central bank's rate hiking plans.